[Immunosuppressive therapy in experimental and clinical liver transplantation].
D000707:Anaphylaxis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000008:administration & dosage* / Q000009:adverse effects; D001379:Azathioprine / Q000008:administration & dosage* / Q000009:adverse effects; D003864:Depression, Chemical; D004285:Dogs; D004342:Drug Hypersensitivity; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006084:Graft Rejection; D006168:Guinea Pigs; D006801:Humans; D007166:Immunosuppressive Agents; D007273:Injections, Intramuscular; D016030:Kidney Transplantation; D007970:Leukopenia / Q000139:chemically induced; D008111:Liver Function Tests; D016031:Liver Transplantation; D009393:Nephritis / Q000139:chemically induced; D011817:Rabbits; D051381:Rats; D012713:Serum Sickness / Q000209:etiology; D013276:Stomach Ulcer / Q000139:chemically induced; D013552:Swine; D014181:Transplantation Immunology / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000961:Antilymphocyte Serum; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D001379:Azathioprine
Beitrag zur immunosuppresiven Therapie bei der experimentellen und klinischen Lebertransplantation.